Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 6 of 6 entries
View as:

Study of AR-67 (Formerly DB-67) in Adult Patients With Refractory or Metastatic Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00389480 Org: User:
Start: 10/31/06 End: 05/31/09 Due: 05/31/10

Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02052128 Org: User:
Start: 01/31/14 End: 04/30/16 Due: 04/30/17

Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00978523 Org: User:
Start: 08/31/09 End: 11/30/13 Due: 11/30/14

Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT00956787 Org: User:
Start: 06/30/09 End: 12/31/14 Due: 12/31/15

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01124539 Org: User:
Start: 12/31/09 End: 02/28/15 Due: 02/28/16

Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02049190 Org: User:
Start: 02/28/14 End: 12/31/17 Due: 12/31/18